IndraLab

Statements


YOD1 inhibits ERK. 3 / 3
| 3

reach
"YOD1 stabilizes the E3 ligase TRIM33 and inhibits the ERK/beta-catenin signaling pathway."

reach
"Conversely, increased YOD1 expression blocks ERK signaling by stabilizing TRIM33 activation, thereby inhibiting tumor invasion and lymph node metastasis in squamous cell carcinoma of the head and neck [25]."

reach
"Using the western blot, we found that YOD1 inhibited the activation of ERK and β-catenin signaling pathways in HNSCC cell lines (Fig. 4J and Supplementary Fig. 3)."